Advisory Research Inc Kiniksa Pharmaceuticals, Ltd. Transaction History

Advisory Research Inc

  • $512 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$14.37 - $19.07 $1.99 Million - $2.64 Million
-138,648 Reduced 67.93%
65,450 $1.15 Million
Q3 2023

Nov 13, 2023
BUY
$13.62 - $20.2 $2.36 Million - $3.51 Million
173,546 Added 568.03%
204,098 $3.55 Million
Q2 2023

Aug 14, 2023
SELL
$10.44 - $16.48 $13,801 - $21,786
-1,322 Reduced 4.15%
30,552 $430,000
Q4 2022

Feb 13, 2023
BUY
$11.42 - $17.05 $364,001 - $543,451
31,874 New
31,874 $477,000

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $751M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email